The Process Development Blog

We’re delighted to announce that our founders Mark Barrett and Brian Glennon received the “Pharma Leader” award at the 2022 Pharma Industry Awards during a gala in Dublin this evening. APC also recieved the prostigous "Pharma Company of the Year" award.

APC and VLE are set to give key technical talks at the 2022 AICHE Annual Meeting, Nov 13-18 during the 'Particle Agglomeration and Granulation Processes' and the 'Particle Technology in Product Design and Manufacturing' session.

In the development of Biologics, a lack of proper process understanding and control often leads to an inability to adequately scale a process, product quality drift and costly delays arising from batch failures and concerns of the regulatory authorities which need to be addressed. APC has developed a unique approach designed to mitigate these issues.

Subtle changes in particle size, shape, and distribution can have a major impact on pharmaceutical solubility and stability. Moreover, low bulk densities can cause flow and formulation challenges during processing.

Good crystallization process design, for intermediates or final APIs, can save you months of time during development. However, crystallization of stereoisomers can be particularly challenging.

In this webinar, we share methods to screen and optimize reactions under extreme time constraints using flow chemistry setups integrated with PAT.